The Novavax vaccine is 96% effective against the original coronavirus, 86% against the British variant in a trial in the United Kingdom
The Novavax vaccine is 96% effective against the original coronavirus, 86% against the British variant in a trial in the United Kingdom
The Novavax vaccine is 96% effective against the original coronavirus, 86% against the British variant in a trial in the United Kingdom
The UK considers vaccines to be 80% effective in preventing hospitalizations in those over 80 years of age
